Showing posts from March, 2024

A global commitment to the responsible development of AI tools

Dear Rosetta community, Scientists in our community led an effort to develop a framework for the responsible development of AI tools for the life sciences. By establishing a framework of guiding principles, we're at the forefront of promoting safety, security, and ethical responsibility in the development of AI tools. Our commitment deeply embeds biosecurity and ethical considerations into AI advancements, advocating for openness and global cooperation to tackle the pressing challenges of health, energy, and environmental sustainability. This endeavor not only steers AI technology towards responsible growth but also aims to spark breakthroughs that benefit humanity at large. This voluntary commitment has been signed by 154 leading scientists from 28 countries, including Nobel laureate of 2018 Frances Arnold, Microsoft's Chief Scientific Officer Eric Horvitz, the 2018 Turing award winner Yann LeCun, and the Former White House Senior Director for Global Health Security and Biodef

Announcing Rosetta's Transition to a Public Repository (including Licensing Changes)

Dear Rosetta Community and users of Rosetta, We're excited to announce that we have moved the Rosetta code repository to a public repository! We have made this move to honor our longstanding philosophy of sharing our work publicly and making it broadly accessible to scientists. This change marks a new chapter for Rosetta, where future developments will be more collaborative and accessible.  This move required crucial changes to our workflow and licensing terms that are designed to streamline contributions to our platform. The new repository is accessible at . Licensing adjustments: The repository's public status means that non-commercial users no longer need to explicitly sign up for a license to access Rosetta. However, despite being publicly accessible, Rosetta is not open source; redistribution restrictions and other licensing restrictions remain in place for all users. For our commercial users, the existing license will continue as